NCT04923984View on ClinicalTrials.gov

Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Subdural Hematoma
Interventions
PROCEDURE

Embolization of the middle meningeal artery

embolization of the middle meningeal artery with an embolic agent.

Trial Locations (1)

R3A 1R9

RECRUITING

Health Sciences centre, Winnipeg MB

All Listed Sponsors
lead

University of Manitoba

OTHER